178 related articles for article (PubMed ID: 1348530)
1. Subcutaneous tocolytic infusion therapy for patients at very high risk for preterm birth.
Allbert JR; Wise CA; Lou CH; Gookin KS; Parmenter MA; Morrison JC
J Perinatol; 1992 Mar; 12(1):28-31. PubMed ID: 1348530
[TBL] [Abstract][Full Text] [Related]
2. Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.
Landau R; Morales MA; Antonarakis SE; Blouin JL; Smiley RM
Clin Pharmacol Ther; 2005 Dec; 78(6):656-63. PubMed ID: 16338281
[TBL] [Abstract][Full Text] [Related]
3. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
de la Torre L; Istwan NB; Desch C; Rhea DJ; Roca L; Stanziano GJ; González-Quintero VH
Am J Perinatol; 2008 Oct; 25(9):555-60. PubMed ID: 18773381
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery.
Wenstrom KD; Weiner CP; Merrill D; Niebyl J
Am J Perinatol; 1997 Feb; 14(2):87-91. PubMed ID: 9259905
[TBL] [Abstract][Full Text] [Related]
5. Tocolytic therapy for acute preterm labor.
Abramovici A; Cantu J; Jenkins SM
Obstet Gynecol Clin North Am; 2012 Mar; 39(1):77-87. PubMed ID: 22370109
[TBL] [Abstract][Full Text] [Related]
6. Tocolysis for recurrent preterm labor using a continuous subcutaneous infusion pump.
Allbert JR; Johnson C; Roberts WE; Martin RW; Gookin KS; Morrison JC
J Reprod Med; 1994 Aug; 39(8):614-8. PubMed ID: 7996525
[TBL] [Abstract][Full Text] [Related]
7. [Tocolysis, use of beta-sympatomimetics for threatening preterm delivery: a critical review].
Rozenberg P
J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):221-30. PubMed ID: 11397997
[TBL] [Abstract][Full Text] [Related]
8. Tocolysis of preterm contractions does not improve preterm delivery rate or perinatal outcomes.
Sciscione AC; Stamilio DM; Manley JS; Shlossman PA; Gorman RT; Colmorgen GH
Am J Perinatol; 1998 Mar; 15(3):177-81. PubMed ID: 9572373
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
Worldwide Atosiban versus Beta-agonists Study Group
BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy and economic outcomes in patients treated for recurrent preterm labor.
Fleming A; Bonebrake R; Istwan N; Rhea D; Coleman S; Stanziano G
J Perinatol; 2004 Apr; 24(4):223-7. PubMed ID: 14999214
[TBL] [Abstract][Full Text] [Related]
11. beta-Agonist tocolytic therapy.
Lam F; Gill P
Obstet Gynecol Clin North Am; 2005 Sep; 32(3):457-84. PubMed ID: 16125044
[TBL] [Abstract][Full Text] [Related]
12. Use of the subcutaneous terbutaline pump for long-term tocolysis.
Lam F; Gill P; Smith M; Kitzmiller JL; Katz M
Obstet Gynecol; 1988 Nov; 72(5):810-3. PubMed ID: 3173932
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous tocolytic infusion therapy for patients at very high risk for preterm birth.
Catanzarite V
J Perinatol; 1992 Dec; 12(4):387-8. PubMed ID: 1479468
[No Abstract] [Full Text] [Related]
14. [Tocolysis].
Spätling L
Z Geburtshilfe Neonatol; 1997; 201 Suppl 1():25-9. PubMed ID: 9410526
[TBL] [Abstract][Full Text] [Related]
15. Risk of preterm delivery from preterm labor in high-risk patients.
Roberts WE; Morrison JC; Perry KG; Floyd RC; McLaughlin BN; Fox MD
J Reprod Med; 1995 Feb; 40(2):95-100. PubMed ID: 7738935
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy prolongation in triplet pregnancies. Oral vs. continuous subcutaneous terbutaline.
Elliott JP; Bergauer NK; Jacques DL; Coleman SK; Stanziano GJ
J Reprod Med; 2001 Nov; 46(11):975-82. PubMed ID: 11762154
[TBL] [Abstract][Full Text] [Related]
17. Uterine contraction frequency before and after successful tocolytic therapy for preterm uterine contractions.
Newman RB; Johnson F; Das A; Goldenberg RL; Swain M; Moawad A; Sibai BM; Caritis SN; Miodovnik M; Paul RH; Dombrowski MP; Collins Sharp BA; Fischer M
J Reprod Med; 2003 Nov; 48(11):843-9. PubMed ID: 14686015
[TBL] [Abstract][Full Text] [Related]
18. [Nitroglycerin patch for tocolysis--a prospective randomized comparison with fenoterol by infusion].
Schleussner E; Richter S; Gross W; Kähler C; Möller A; Möller U; Seewald HJ
Z Geburtshilfe Neonatol; 2001; 205(5):189-94. PubMed ID: 11727665
[TBL] [Abstract][Full Text] [Related]
19. Maximum possible impact of tocolytics in preventing preterm birth: a retrospective assessment.
Menticoglou SM; Morrison I; Harman CR; Manning FA; Lange IR
Am J Perinatol; 1992; 9(5-6):394-7. PubMed ID: 1418142
[TBL] [Abstract][Full Text] [Related]
20. The interval to spontaneous delivery following discontinuation of maintenance tocolysis.
Jones JS; Morrison J; Istwan N; Rhea D; Collins A; Stanziano G
J Matern Fetal Neonatal Med; 2006 Jun; 19(6):331-5. PubMed ID: 16801308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
